National Vision Holdings

EYENASDAQUSD

THESIS ALERT

Email me when the EYE thesis changes

Evidence-based analysis, not personalized investment advice. Every alert email carries an unsubscribe link.

Follow on X
$18.09
−$0.92 (−4.84%)Today 1M +13.97%
After hours$17.93−0.89%

Updated Nov 11, 4:00 PM ET · Regular session · May be delayed

Source valuation snapshot. Not a live recalculation.
Latest filed annual earnings; price snapshot date unavailable. Not forward P/E.
Diluted earnings per share from the latest filed annual.
$19.01
Prior regular-session close from the quote source.
$17.39–$18.88
Regular-session low and high so far today.
3.3M
Regular-session shares traded · Nov 11, 4:00 PM ET.
Not yet confirmed
The company has not confirmed its next report date. Reported quarters are available in the chart’s Earnings view.
$14.75–$30.02
52-week trading low and high returned by the quote source.

Understand the Business

Why the Stock Moved

Period-matched expectations history is not yet available. Current metrics are not a substitute for a historical explanation.

The core investment thesis

Own EYE if its low-price eye-care model converts recurring vision needs into profitable traffic, but the stock only works if margin recovery and cash generation prove durable rather than cyclical.

EYE price history

Latest price$18.09Today−$0.92 (-4.84%)
EYE +6.85%S&P 500 -2.42%Since first plotted close
4 hours

Loading recent earnings…

Investment thesis

What must happen next

5 MATERIAL PROPOSITIONS
  • National Vision’s affordability-led optical model remains relevant enough to pull consumers into stores for recurring vision-correction needs, rather than losing the value shopper to online sellers, mass merchants or insurers’ preferred networks.StrengtheningMateriality: High

    GAAP annual revenue increased from $1.756 billion in FY2024 to $1.823 billion in FY2025 and $1.987 billion in FY2026. If the traffic engine holds, revenue recovery can fund the turnaround; if value consumers migrate elsewhere, scale becomes a fixed-cost burden.

    Watch: Warby Parker or other online optical sellers materially reduce the friction and price gap for prescription eyewear, weakening the need for value-store visits.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    GAAP annual revenue increased from $1.756 billion in FY2024 to $1.823 billion in FY2025 and $1.987 billion in FY2026.

    Open source ↗
  • In-store exam availability is a necessary traffic driver for National Vision’s retail model, so optometrist and associate capacity must remain sufficient for the value proposition to convert demand into eyewear sales.HoldingMateriality: High

    The company reported 13,138 full-time and part-time associates as of March 4, 2026. Adequate doctor capacity supports traffic and conversion; a staffing bottleneck would cap growth before demand shows up in the financials.

    Watch: A shortage of optometrists raises wage rates or leaves appointment slots unfilled, reducing exam-driven store traffic.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    The company reported 13,138 full-time and part-time associates as of March 4, 2026.

    Open source ↗
  • The turnaround depends on store, lab and distribution scale translating recovering traffic into GAAP operating leverage, not revenue bought through promotions, labor inflation or adverse mix.HoldingMateriality: Medium

    GAAP annual operating income improved from a loss of $10.4 million in FY2025 to income of $58.8 million in FY2026. Operating leverage is what turns an optical retailer from a revenue story into an earnings and equity-value story.

    Watch: Competitors force sustained price promotions in eyeglasses or contact lenses, preventing gross-margin recovery.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    GAAP annual operating income improved from a loss of $10.4 million in FY2025 to income of $58.8 million in FY2026.

    Open source ↗
  • National Vision’s retail cash cycle and working-capital discipline must keep the turnaround self-funding despite thin GAAP earnings, so reinvestment does not require heavy dilution or balance-sheet stress.StrengtheningMateriality: Medium

    GAAP annual operating cash flow was positive in each supplied year from FY2023 through FY2026. Positive operating cash flow gives management time to fix margins; weak cash conversion would turn an operating turnaround into a financing problem.

    Watch: Inventory requirements rise because of product mix, supply-chain disruption or slower sell-through, consuming cash before revenue weakens.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    GAAP annual operating cash flow was positive in each supplied year from FY2023 through FY2026.

    Open source ↗
  • The balance sheet gives National Vision less room for error than a clean-growth retailer, so the operating recovery must continue before liquidity or lease/debt constraints start dictating strategy.WeakeningMateriality: Medium

    The company still reported positive cash of $38.7 million at FY2026 year-end. If liquidity tightens, management may have to slow investment, close stores, renegotiate terms or issue equity at unattractive prices.

    Watch: A refinancing, lease-renewal or vendor-term shock raises required cash outflows before profitability fully normalizes.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    The company still reported positive cash of $38.7 million at FY2026 year-end.

    Open source ↗
Full investment case & evidence

Loading the original research archive…

Original research

National Vision’s affordability-led optical model remains relevant enough to pull consumers into stores for recurring vision-correction needs, rather than losing the value shopper to online sellers, mass merchants or insurers’ preferred networks. If the traffic engine holds, revenue recovery can fund the turnaround; if value consumers migrate elsewhere, scale becomes a fixed-cost burden.

In-store exam availability is a necessary traffic driver for National Vision’s retail model, so optometrist and associate capacity must remain sufficient for the value proposition to convert demand into eyewear sales. Adequate doctor capacity supports traffic and conversion; a staffing bottleneck would cap growth before demand shows up in the financials.

The turnaround depends on store, lab and distribution scale translating recovering traffic into GAAP operating leverage, not revenue bought through promotions, labor inflation or adverse mix. Operating leverage is what turns an optical retailer from a revenue story into an earnings and equity-value story.

National Vision’s retail cash cycle and working-capital discipline must keep the turnaround self-funding despite thin GAAP earnings, so reinvestment does not require heavy dilution or balance-sheet stress. Positive operating cash flow gives management time to fix margins; weak cash conversion would turn an operating turnaround into a financing problem.

The balance sheet gives National Vision less room for error than a clean-growth retailer, so the operating recovery must continue before liquidity or lease/debt constraints start dictating strategy. If liquidity tightens, management may have to slow investment, close stores, renegotiate terms or issue equity at unattractive prices.

All standing thesis claims
Original report summary

its low-price eye-care model converts recurring vision needs into profitable traffic, but the stock only works if margin recovery and cash generation prove durable rather than cyclical.

Evidence assessed Nov 10, 2026. Expand each conclusion for its evidence and what would change it. Thesis evidence—not a buy or sell recommendation.

Bull case and bear case

Bull case and bear case for National Vision Holdings

Where the evidence on National Vision Holdings disagrees: Mixed on the latest evidence (Nov 10, 2026). Of its 5 thesis points, 2 strengthening, 2 holding and 1 weakening.

Bull case: what the evidence supports

  • National Vision’s affordability-led optical model remains relevant enough to pull consumers into stores for recurring vision-correction needs, rather than losing the value shopper to online sellers, mass merchants or insurers’ preferred networks.

    sec.gov ↗

  • In-store exam availability is a necessary traffic driver for National Vision’s retail model, so optometrist and associate capacity must remain sufficient for the value proposition to convert demand into eyewear sales.

    sec.gov ↗

  • The turnaround depends on store, lab and distribution scale translating recovering traffic into GAAP operating leverage, not revenue bought through promotions, labor inflation or adverse mix.

    sec.gov ↗

  • National Vision’s retail cash cycle and working-capital discipline must keep the turnaround self-funding despite thin GAAP earnings, so reinvestment does not require heavy dilution or balance-sheet stress.

    sec.gov ↗

Bear case: what the evidence questions

  • The balance sheet gives National Vision less room for error than a clean-growth retailer, so the operating recovery must continue before liquidity or lease/debt constraints start dictating strategy.

    sec.gov ↗

Thesis-Break Engine

Thesis-break watch · National Vision Holdings

12 mo agonow
Trailing daily price. No thesis break has crossed here, so there is no break base rate to project.

No break has crossed National Vision Holdings’s thesis. Its break conditions are checked against every new filing as it lands.

How the Thesis-Break Engine works →Historical outcomes are measured against the market after past breaks of the same kind, across all companies. Not a prediction.

MARKET + FINANCIAL SNAPSHOT

The numbers behind the thesis

Sourced from filings and market data

What Changed

  1. Mixed
    Reported results of operations (earnings release).

    National Vision Holdings filed an SEC 8-K on 2026-08-12: Reported results of operations (earnings release). It is a dated development that tests the current thesis.

  2. Mixed
    Regulation FD disclosure.

    National Vision Holdings filed an SEC 8-K on 2026-06-03: Regulation FD disclosure. It is a dated development that tests the current thesis.

  3. Mixed
    Reported results of operations (earnings release).

    National Vision Holdings filed an SEC 8-K on 2026-05-13: Reported results of operations (earnings release). It is a dated development that tests the current thesis.

Risks / falsifiers

What could break the thesis

  • Warby Parker or other online optical sellers materially reduce the friction and price gap for prescription eyewear, weakening the need for value-store visits.
  • A shortage of optometrists raises wage rates or leaves appointment slots unfilled, reducing exam-driven store traffic.
  • Competitors force sustained price promotions in eyeglasses or contact lenses, preventing gross-margin recovery.
  • Inventory requirements rise because of product mix, supply-chain disruption or slower sell-through, consuming cash before revenue weakens.
  • A refinancing, lease-renewal or vendor-term shock raises required cash outflows before profitability fully normalizes.

EYE news

Loading headlines…

Financial statements

EYE income statement

Annual filed results · USD · Oldest to newest. Margins are calculated from the reported figures.

EYE: quick answers

When does National Vision Holdings (EYE) report earnings next?
National Vision Holdings's next results were projected for November 4, 2026, from the dates of its own results filings with the SEC, and it has not filed them yet. It last reported on August 12, 2026. Earnings calendar
What is EYE's short interest?
As of October 30, 2026, 16.4M EYE shares were sold short, 20.8% of its shares outstanding, up 4.4% from the count before. At the stock's average daily volume that is 9.0 days to cover. FINRA publishes the count twice a month. EYE short interest history
Have members of Congress traded EYE?
2 trades in EYE have been disclosed under the STOCK Act by members of Congress, the President or senior officials, none in reports made public in the last 90 days. Every disclosed EYE trade
Which well-known investors own EYE?
2 of the 37 well-known funds tracked here reported EYE shares in their latest 13F filings. By share of the fund's portfolio: Glenview Capital Management, 1.1%; Bridgewater Associates (Ray Dalio), 0.0%. Fund portfolios

EYE in well-known investors’ portfolios

2 of 37 funds reported EYE shares in their latest 13F filing. A 13F shows quarter-end positions and arrives up to 45 days later.

FundOf its portfolioValueChangeQuarter
Glenview Capital Management1.1%$59.0M—Q2 2026
Ray DalioBridgewater Associates0.01%$2.2M+340.9%Q2 2026

Every fund’s portfolio

ScoutJUST THIS STORY

LET’S MAKE THIS USEFUL · 1 OF 5

How would you like me to explain this?

Tell me what you want from this read. Start with a quick note, then adjust the details. Your other stories stay as they are.

We’ll remember your view of this story. The published article stays unchanged.

THIS STORY’S READING VIEWStandard · The whole picture

Clear explanations with context. Both sides of the evidence.